Date published: 2025-10-10

021-6093-6350

SCBT Portrait Logo
Seach Input

EG245651 抑制因子

EG245651 inhibitors represent a specific class of chemical compounds that are designed to target and modulate the activity of a protein or enzyme referred to as EG245651. While the exact structural characteristics of these inhibitors can vary, they typically share a common pharmacophore that is essential for binding to the active or allosteric sites of the target protein. This binding is often achieved through a combination of non-covalent interactions, such as hydrogen bonds, hydrophobic interactions, and van der Waals forces. The molecular architecture of EG245651 inhibitors is crafted to ensure high affinity and selectivity towards their target, minimizing interactions with other proteins and reducing off-target effects. Additionally, these compounds are usually optimized for stability, solubility, and membrane permeability, ensuring effective engagement with the target protein in various biological environments.

Research into EG245651 inhibitors involves understanding the conformational dynamics of the target protein, as well as the kinetic and thermodynamic properties that govern inhibitor binding. Structural biology techniques, such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, are often employed to elucidate the binding modes of these inhibitors at atomic resolution. Computational modeling and molecular dynamics simulations also play a crucial role in predicting the interaction patterns and in optimizing the chemical structures of the inhibitors for enhanced efficacy and specificity. Further studies may involve biochemical assays to determine the potency of these inhibitors in modulating the activity of EG245651 and to assess their effects on various downstream signaling pathways and cellular processes. The development of EG245651 inhibitors is a significant area of chemical biology, contributing to the broader understanding of protein function and regulation within complex biological systems.

関連項目

Items 1 to 10 of 11 total

展示:

产品名称CAS #产品编号数量价格应用排名

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
¥1264.00
¥1839.00
¥10470.00
19
(1)

Trametinib是一种MEK抑制剂,可阻断MAPK通路。通过抑制MEK,它通过改变细胞内信号级联间接影响Gm4995的表达和功能,从而影响与MAPK通路相关的调节机制。

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
¥745.00
¥2471.00
¥4705.00
97
(3)

Wortmannin是一种影响PI3K/AKT通路的PI3K抑制剂。它的抑制作用会扰乱下游信号传导,通过改变与 PI3K/AKT 相关的细胞过程间接影响 Gm4995,并可能通过扰乱细胞内信号传导影响其表达和功能。

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
¥2550.00
¥9545.00
1
(0)

JQ1 是一种溴链抑制剂,能破坏 BET 蛋白与染色质的相互作用。由于 Gm4995 可能受到表观遗传调控,JQ1 对染色质可及性的影响间接影响了 Gm4995 的表达,从而可能通过改变转录调控机制来调节其功能。

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
¥688.00
¥936.00
¥3937.00
155
(1)

BAY 11-7082抑制NF-κB的激活,从而阻断下游信号传导。由于Gm4995可能受NF-κB影响,因此抑制NF-κB可通过改变其在各种细胞环境中的转录调控,间接影响Gm4995的表达和功能。

SB-216763

280744-09-4sc-200646
sc-200646A
1 mg
5 mg
¥790.00
¥2234.00
18
(1)

SB216763 可抑制 GSK-3,从而影响 Wnt 通路。鉴于细胞通路的相互关联性,其对 Wnt 信号转导的影响会间接影响 Gm4995。这可能会通过干扰与 Wnt 通路调节相关的信号级联,导致 Gm4995 的表达和功能发生改变。

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
¥993.00
¥3858.00
284
(5)

SB203580 是 p38 MAPK 的特异性抑制剂。通过靶向 p38 MAPK,它影响了 MAPK 信号通路。这种间接抑制可能会影响 Gm4995,因为 MAPK 通路与各种细胞过程相互关联,可能会通过改变信号级联影响其表达和功能。

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
¥699.00
¥1749.00
¥3610.00
233
(4)

雷帕霉素抑制mTOR,后者是细胞过程的关键调节因子。通过影响mTOR信号传导,它间接影响Gm4995,可能通过破坏与mTOR介导的细胞过程相关的细胞内信号传导通路来改变其表达和功能。

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
¥301.00
¥1128.00
257
(3)

SP600125抑制JNK,MAPK家族的一员。它对MAPK通路的影响会间接影响Gm4995,通过改变与JNK介导的细胞反应相关的信号级联,从而可能影响其表达和功能。

AZD2014

1009298-59-2sc-364420
5 mg
¥3418.00
2
(0)

AZD2014 是一种影响 mTOR 信号通路的 mTOR 抑制剂。其抑制作用会扰乱下游信号传导,通过可能改变 mTOR 通路间接影响 Gm4995。这种影响可能会通过扰乱细胞内信号转导而导致 Gm4995 的表达和功能发生变化。

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
¥857.00
¥2437.00
101
(4)

顺铂可诱导DNA损伤,影响细胞进程。这可能会通过破坏细胞稳态间接影响Gm4995,通过改变与DNA损伤反应通路相关的调节机制,影响其表达和功能。